Sign in

Research summary ·

Liver transplantation as a treatment option for neuroendocrine liver metastases: a systematic review.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This review looked at liver transplants for neuroendocrine tumors that spread to the liver. The authors gathered results from published reports. They searched MEDLINE (PubMed) and Scopus. They followed PRISMA guidelines. The aim was to review results after the transplant in these patients. They collected data on how patients did after the transplant.

What they found

The search found 2471 articles, and 25 were picked. These held data on 1005 patients. Their mean age was 47.9 years, and most were male. The tumors most often began in the pancreas, then the small intestine. Disease-free survival was 25.3 months. Overall survival was 38.5 months.

What it means for patients

The authors say liver transplant appears to give a survival benefit. This applies to selected cases. They had diffuse liver spread and no spread outside the liver.

Why it is not certain yet

The abstract describes published reports of patients who had a transplant. It does not describe a group without a transplant. The words selected cases mean the findings may not apply to everyone. The abstract does not say how patients were chosen.

Source

Liver transplantation as a treatment option for neuroendocrine liver metastases: a systematic review.

PubMed · PMID 42913616

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Neuroendocrine tumours publications